Overview Financials News + Filings Key Docs Ownership
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 20-F | 20-F | 20-F | 20-F |
| Revenues: |
| NETHERLANDS | | | | 19.6 |
| UNITED STATES | 163.9 | 163.7 | 125.5 | 81.4 |
| ISRAEL | 3.3 | 2.4 | 0.9 | 0.3 |
| Other | 94.0 | 63.1 | 43.4 | 29.3 |
| Total revenues | 261.2 | 229.1 | 169.7 | 130.6 |
| Revenue growth [+] | 14.0% | 35.0% | 30.0% | |
| UNITED STATES | 0.1% | 30.5% | 54.1% | |
| ISRAEL | 37.5% | 166.7% | 216.9% | |
| Cost of goods sold | 126.2 | 106.2 | 76.9 | 64.9 |
| Gross profit | 135.1 | 123.0 | 92.8 | 65.7 |
| Gross margin | 51.7% | 53.7% | 54.7% | 50.3% |
| Selling, general and administrative [+] | 171.7 | 123.1 | 63.0 | 54.5 |
| Sales and marketing | 87.7 | 70.2 | 41.1 | 36.6 |
| General and administrative | 84.0 | 52.9 | 21.9 | 17.9 |
| Research and development | 72.0 | 55.3 | 36.6 | 25.0 |
| EBITDA [+] | -105.0 | -53.4 | -5.4 | -13.2 |
| EBITDA growth | 96.6% | 880.3% | -58.6% | |
| EBITDA margin | -40.2% | -23.3% | -3.2% | -10.1% |
| Depreciation and amortization | 3.6 | 2.0 | 1.4 | 0.7 |
| EBIT [+] | -108.6 | -55.4 | -6.8 | -13.9 |
| EBIT growth | 96.1% | 713.7% | -50.9% | |
| EBIT margin | -41.6% | -24.2% | -4.0% | -10.6% |
| Interest income | 10.2 | 0.6 | 0.1 | 0.1 |
| Interest income | 10.2 | 0.6 | 0.1 | 0.1 |
| Other income (expense), net | 0.5 | -122.5 | -3.6 | 0.1 |
| Pre-tax income | -97.9 | -177.3 | -10.3 | -13.7 |
| Income taxes | 6.0 | 1.6 | 1.1 | 0.5 |
| Net income | -104.0 | -178.9 | -11.3 | -14.2 |
| Net margin | -39.8% | -78.1% | -6.7% | -10.9% |
| |
| Basic EPS [+] | ($0.62) | ($2.34) | ($0.40) | ($0.52) |
| Growth | -73.5% | 478.3% | -22.4% | |
| Diluted EPS [+] | ($0.62) | ($2.34) | ($0.40) | ($0.52) |
| Growth | -73.5% | 478.3% | -22.4% | |
| |
| Shares outstanding (basic) [+] | 167.7 | 76.5 | 28.0 | 27.2 |
| Growth | 119.3% | 172.6% | 3.1% | |
| Shares outstanding (diluted) [+] | 167.7 | 76.5 | 28.0 | 27.2 |
| Growth | 119.3% | 172.6% | 3.1% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|